Lumican is overexpressed in lung adenocarcinoma pleural effusions.

Adenocarcinoma (AdC) is the most common lung cancer subtype and is often associated with pleural effusion (PE). Its poor prognosis is attributable to diagnostic delay and lack of effective treatments and there is a pressing need in discovering new biomarkers for early diagnosis or targeted therapies...

詳細記述

書誌詳細

出版年:	PLoS ONE
主要な著者:	Rocco Cappellesso, Renato Millioni, Giorgio Arrigoni, Francesca Simonato, Brasilina Caroccia, Elisabetta Iori, Vincenza Guzzardo, Laura Ventura, Paolo Tessari, Ambrogio Fassina
フォーマット:	論文
言語:	英語
出版事項:	Public Library of Science (PLoS) 2015-01-01
オンライン･アクセス:	http://europepmc.org/articles/PMC4427354?pdf=render